These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18221996)

  • 1. Unrelated umbilical cord blood transplantation as salvage treatment for engraftment failure following autologous stem cell transplantation.
    Fenk R; Neumann F; Fenk B; Ruf L; Zohren F; Safaian NN; Haas R; Kobbe G
    Leuk Res; 2008 Jul; 32(7):1157-9. PubMed ID: 18221996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autografting followed by a reduced-intensity conditioning unrelated donor cord blood transplantation for a patient with refractory multiple myeloma: successful engraftment with minimal toxicity.
    Ando T; Yujiri T; Tominaga T; Shinya S; Takahashi T; Nomiyama J; Seguchi M; Matsubara A; Fujii Y; Tanizawa Y
    Eur J Haematol; 2005 Feb; 74(2):175-9. PubMed ID: 15654912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical allogeneic haematopoietic stem cell transplantation as salvage therapy for engraftment failure after unrelated and autologous stem cell transplantation: a case report and review of the literature.
    Tan YM; Fu HR; Luo Y; Shi JM; Ye XJ; Zheng YL; Xiao HW; Hu YX; Huang H
    J Int Med Res; 2011; 39(3):950-9. PubMed ID: 21819729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early identification and management of graft failure after unrelated cord blood transplantation.
    Chan KW; Grimley MS; Taylor C; Wall DA
    Bone Marrow Transplant; 2008 Jul; 42(1):35-41. PubMed ID: 18332909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful engraftment of a second transplant from unrelated cord blood identifying acceptable HLA Ag mismatches as treatment for primary graft failure possibly mediated by anti-HLA Abs after 'mega-dose' haploidentical PBSC transplantation.
    Hoshino T; Sakura T; Miyawaki K; Hatsumi N; Takada S; Maruya E; Saji H; Miyawaki S
    Bone Marrow Transplant; 2010 Nov; 45(11):1665-7. PubMed ID: 20190841
    [No Abstract]   [Full Text] [Related]  

  • 7. In utero transplantation of autologous and allogeneic fetal liver stem cells in ovine fetuses.
    Schoeberlein A; Holzgreve W; Dudler L; Hahn S; Surbek DV
    Am J Obstet Gynecol; 2004 Sep; 191(3):1030-6. PubMed ID: 15467585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose.
    Edenfield WJ; Moores LK; Goodwin G; Lee N
    Bone Marrow Transplant; 2000 Feb; 25(4):405-9. PubMed ID: 10723584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children's haematology and oncology group.
    Petterson TE; Gabriel M; Tiedemann K; Teague L; Shaw PJ; Baker D; Bolton-Jones R; Tapp H; Oswald C; Vowels MR; O'Brien TA
    Bone Marrow Transplant; 2009 Feb; 43(3):207-15. PubMed ID: 18806837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.
    Kobayashi K; Maeda Y; Hara Y; Nishie-Kataoka M; Nishimori H; Sugiyama H; Namba N; Kubonishi S; Niiya M; Shinagawa K; Ikeda K; Tanimoto M
    Anticancer Res; 2009 May; 29(5):1763-70. PubMed ID: 19443401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
    Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
    Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark RE; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
    Bone Marrow Transplant; 2008 Dec; 42(11):739-42. PubMed ID: 18724394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cord blood banking for potential future transplantation.
    ; ; Lubin BH; Shearer WT
    Pediatrics; 2007 Jan; 119(1):165-70. PubMed ID: 17200285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful engraftment of cord blood following a one-day reduced-intensity conditioning regimen in two patients suffering primary graft failure and sepsis.
    Shimizu I; Kobayashi H; Nasu K; Otsuki F; Ueki T; Sumi M; Ueno M; Ichikawa N; Nakao S
    Bone Marrow Transplant; 2009 Nov; 44(9):617-8. PubMed ID: 19349955
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.
    Boelens JJ; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Michel G; Ionescu I; Parikh S; Prasad VK; Szabolcs P; Escolar M; Gluckman E; Cavazzana-Calvo M; Kurtzberg J;
    Biol Blood Marrow Transplant; 2009 May; 15(5):618-25. PubMed ID: 19361754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of pure red cell aplasia with autologous stem cell transplantation.
    Park JH; Spitzer T; Kuter DJ
    Am J Hematol; 2007 Sep; 82(9):812-4. PubMed ID: 17546635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization of PML-RARA negative blood stem cells and salvage with autologous peripheral blood stem cell transplantation in children with relapsed acute promyelocytic leukemia.
    Termuhlen AM; Klopfenstein K; Olshefski R; Rosselet R; Yeager ND; Soni S; Gross TG
    Pediatr Blood Cancer; 2008 Oct; 51(4):521-4. PubMed ID: 18493994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Starting granulocyte-colony-stimulating factor (filgrastim) early after autologous peripheral blood progenitor cell transplantation leads to faster engraftment without increased resource utilization.
    Thompson JM; Carlton P; Akard LP; Dugan MJ; Jansen J
    Transfusion; 2009 Mar; 49(3):548-54. PubMed ID: 19040494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.